NCT02637310View on ClinicalTrials.gov

Evaluate the Efficacy and Safety of N02RS1 in Patient With Acute Bronchitis

PHASE2CompletedINTERVENTIONAL

Enrollment

108

Participants

Timeline

Start Date

December 31, 2015

Primary Completion Date

March 31, 2016

Study Completion Date

March 31, 2016

Conditions

Acute Bronchitis

Interventions

DRUG

N02RS1 1200mg

1200mg/day, Three times a day orally, 2 tablets once, 7 days

DRUG

Placebo

1200mg/day, Three times a day orally, 2 tablets once, 7 days

Sponsors

Lead Sponsor

All Listed Sponsors

lead

PharmaKing

INDUSTRY